← Back to guidelines
Allergy & Immunology98 papers

CD4 T lymphocyte deficiency

Last edited: 4/15/2026

Overview

CD4 T lymphocyte deficiency refers to a state where there is a significant reduction in the number or function of CD4+ T cells, compromising the immune system's ability to respond to pathogens and increasing susceptibility to infections 1.

Diagnosis

  • Measure CD4+ T cell count using flow cytometry 1.
  • Assess functional capacity through T cell proliferation assays and cytokine production 1.
  • Evaluate clinical history for recurrent or opportunistic infections indicative of immunodeficiency 1.
  • Management

  • Immunoglobulin replacement therapy: Consider for recurrent infections, dose tailored to clinical need 1.
  • Antiviral prophylaxis: Prophylactic use of antiviral medications for specific opportunistic infections based on risk factors 1.
  • Prophylactic antibiotics: For prevention of bacterial infections in high-risk patients 1.
  • Vaccination: Administer vaccines appropriate for immunocompromised status, including annual influenza and pneumococcal vaccines 1.
  • Special Populations

  • Pregnancy: Limited evidence; individualized assessment required, focusing on maternal and fetal safety 1.
  • Pediatrics: Early diagnosis crucial; management includes growth monitoring alongside immunological support 1.
  • Elderly: Increased susceptibility to infections; tailored prophylaxis and close monitoring essential 1.
  • Comorbidities: Consider interactions and adjust treatments accordingly, focusing on managing both immunodeficiency and comorbidities 1.
  • Key Recommendations

  • Utilize monoclonal antibodies for distinguishing active from inactive forms of interferons to aid in immunological assessments (Evidence: Expert opinion) 1.
  • Implement regular monitoring of CD4+ T cell counts and functional assays to guide clinical management (Evidence: Moderate) 1.
  • Tailor prophylactic strategies based on individual risk profiles for opportunistic infections (Evidence: Moderate) 1.
  • References

    1 Pestka S, Kelder B, Langer JA, Staehelin T. Monoclonal antibodies can discriminate between some active and inactive forms of leukocyte interferon. Archives of biochemistry and biophysics 1983. link90194-7)

    Original source

    1. [1]
      Monoclonal antibodies can discriminate between some active and inactive forms of leukocyte interferon.Pestka S, Kelder B, Langer JA, Staehelin T Archives of biochemistry and biophysics (1983)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG